
Opinion|Videos|June 25, 2024
Key Takeaways on mBC and eBC
Key opinion leaders (KOLs) provide key takeaways on metastatic breast cancer and early breast cancer, emphasizing the enthusiasm surrounding recent advances in the field and the potential for improved patient outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- What are your key takeaways on the evolving treatment landscape for metastatic breast cancer and early breast cancer?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
MONALEESA Data Reveal Robust Long-Term Disease Control With Ribociclib
2
A Supplemental Blood Test to Bridge Gaps in Breast Cancer Screening Access
3
Advancing Treatment After CDK4/6 Inhibitor Progression in HR+/HER2– Breast Cancer
4
AI-Powered Deep Proteomics Enables Early, Non-Imaging Detection of Breast Cancer With MRI-Comparable Accuracy
5






















































































































































































































